Sixth annual Jonathan E. Rhoads lecture. Enteral Nutrition: Tube Feeding in Acute and Chronic Illness

Randall, Henry T.

doi:10.1177/0148607184008002113

Cited by 68 publications

(21 citation statements)

References 67 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Enteral Therapymentioning

confidence: 99%

“…beef broth, w ine, brandy and pancreatic tissue have been administered to patients rectally since An cient Egyptian times [113], John Hunter in 1790 successfully used a 'tube' passed through the mouth into the stomach to feed a patient who was unable to swallow because of paraly sis of the muscles of deglutition. Interestingly this 'tube" was designed by a watchmaker and consisted of eel skin wrapped round a flexible whalebone [113]. Now unweighted fine-bore enteral tubes of polyurethane, silicone rubber or less commonly polyvinyl chloride are avail able and can be tolerated when passed through the nose for periods of several weeks [114], Feeding through a percutaneous endo scopic gastrostromy may be safer and easier to manage for long-term enteral feeding [115].…”

Section: Enteral Therapymentioning

confidence: 99%

See 1 more Smart Citation

The Short Bowel Syndrome: What’s New and Old?

Nightingale

Lennard-Jones²

1993

Dig Dis

View full text Add to dashboard Cite

Conditions which resulted in colonic preservation such as strangulated hernia, intestinal volvulus, and mesenteric infarction were once the main reasons for a major intestinal resection leading to the short bowel syndrome. Now Crohn’s disease is the most common underlying diagnosis; such patients often have a jejunostomy. A measurement of the residual jejunal length from the duodenojejunal flexure makes possible predictions of patient outcome. Patients with a jejunostomy and less than 100 cm jejunum usually need long-term parenteral support, whereas 50 cm or more of jejunum usually suffices for adequate oral nutrition if the colon is preserved. While patients with and without a colon have problems with nutrient absorption, those with a jejunostomy also have problems of water, sodium and magnesium losses. Stomal losses may exceed oral intake and all such patients (‘secretors’) need parenteral supplements. Fluid and sodium losses can be reduced by octreotide, omeprazole or H₂ blockers but not sufficiently to avoid the need for intravenous supplements. Colonic preservation increases the incidence of calcium oxalate renal stones (20%). Patients with and without a colon have a high prevalence of gallstones (40%). Clinically important intestinal adaptation occurs in those with a colon but not in those with a jejunostomy. Many surgical techniques, including small bowel transplantation, have been suggested to improve absorption, but as the quality of life of most patients with a short bowel is good with current treatments, they are not at present recommended.

show abstract

Section: Enteral Therapymentioning

confidence: 99%

Section: Enteral Therapymentioning

confidence: 99%

The Short Bowel Syndrome: What’s New and Old?

Nightingale

Lennard-Jones²

1993

Dig Dis

View full text Add to dashboard Cite

show abstract

“…Historically it must be remembered that the very earliest low residue enteral diets were specifically designed not only to provide balanced nutrition to astronauts in space but also to reduce their stool weight and stool frequency. 3 Subsequently it was realised that one clinical advantage of low residue diets was that they had a low viscosity and could be administered easily through 'fine bore' nasogastric or nasoenteric feeding tubes. Furthermore as it became clear that there could even be a number of therapeutic advantages in administering low residue diets4 their widespread use became accepted without question.…”

Section: Fibre and Enteral Nutritionmentioning

confidence: 99%

Fibre and enteral nutrition.

Silk

1989

Gut

View full text Add to dashboard Cite

“…Patient feeding by nasogastric tube has gained increased significance in recent years, and techniques have improved concurrently [1][2][3]. Thus, the number of patient-days for which nasogastric feeding was provided in our intensive care unit has grown from 5% in 1986 to 30% in 1995 [4].…”

Section: Introductionmentioning

confidence: 99%

“…Of the 29 patients observed, 15 (52%) were fitted with a nasogastric tube, ten (34%) with a percutaneous endoscopic gastrostomy and four (14%) with a jejunostomy. The average number of drugs was 6.5 per patient (range [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]. Analgesics represented 16% of all drugs administered in this manner and antipsychotics 13%.…”

Section: Introductionmentioning

confidence: 99%

The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube

Podilsky

Berger-Gryllaki

Testa

et al. 2009

Eur J Clin Pharmacol

View full text Add to dashboard Cite

Aims To characterize and compare the pharmacokinetic profiles of bromazepam, omeprazole and paracetamol when administered by the oral and nasogastric routes to the same healthy cohort of volunteers. Methods In a prospective, monocentric, randomized crossover study, eight healthy volunteers received the three drugs by the oral (OR) and nasogastric routes (NT). Sequential plasma samples were analyzed by high-performance liquid chromatography-UV, pharmacokinetic parameters (C max , AUC 0À1 , t ½ , k e , t max ) were compared statistically, and C max , AUC 0À1 and t max were analyzed for bioequivalence.

show abstract

Sixth annual Jonathan E. Rhoads lecture. Enteral Nutrition: Tube Feeding in Acute and Chronic Illness

Cited by 68 publications

References 67 publications

The Short Bowel Syndrome: What’s New and Old?

The Short Bowel Syndrome: What’s New and Old?

Fibre and enteral nutrition.

The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube

Contact Info

Product

Resources

About